Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    1230.14
Show Display Options
Rank Status Study
1 Active, not recruiting Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: placebo;   Drug: volasertib;   Drug: low dose cytarabine

Study has passed its completion date and status has not been verified in more than two years.